AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 DEC 2 - (NewsRx.com & NewsRx.net) -- Grant Life Sciences, Inc., (GRTV) announced an agreement with Allogen Laboratories, a wholly owned subsidiary of the Cleveland Clinic Foundation, wherein Allogen will perform testing and validation studies on Grant's protein-based HPV (human papillomavirus)/cervical cancer diagnostic technology and kits.
As a part of the agreement, Allogen will screen precancerous and cervical cancer patient samples over Grant's proprietary test to determine the efficacy of the technology. The test, which consists of synthetic peptides derived from human papillomavirus proteins, would be the first direct diagnostic to directly detect cervical cancer.
Stan Yakatan, chairman and CEO of Grant Ventures, stated, "We are ...
Source: HighBeam Research, Grant Ventures announces collaboration with Cleveland Clinic...